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Research article Predictors of functional outcome vary by the 
hemisphere of involvement in major ischemic 
stroke treated with intra-arterial therapy: a 
retrospective cohort study
Albert J Yoo*1,2, Javier Romero1, Reza Hakimelahi1, Raul G Nogueira2,3, James D Rabinov2, Johnny C Pryor2, R 
Gilberto González1, Joshua A Hirsch2 and Pamela W Schaefer1
Abstract
Background: Conflicting data exists regarding the effect of hemispheric lateralization on acute ischemic stroke 
outcome. Some of this variability may be related to heterogeneous study populations, particularly with respect to the 
level of arterial occlusion. Furthermore, little is known about the relationship between stroke lateralization and 
predictors of outcome. The purpose of this study was to characterize the impact of stroke lateralization on both 
functional outcome and its predictors in a well-defined population of anterior circulation proximal artery occlusions 
treated with IAT.
Methods: Thirty-five consecutive left- and 35 consecutive right-sided stroke patients with intracranial ICA and/or MCA 
occlusions who underwent IAT were retrospectively analyzed. Ischemic change on pre-treatment imaging was 
quantified. Reperfusion success was graded using the Mori scale. Good outcome at three months was defined as an 
mRS ≤ 2. Left- and right-sided strokes were compared for outcome and its predictors.
Result: Of 70 patients with median NIHSS score of 18 (IQR, 14-21), 19 (27.1%) had a good outcome. There were 21 
terminal ICA and 49 MCA occlusions. There was no difference in the rate of good outcomes between left- (n = 9) and 
right-sided (n = 10) strokes (p = 0.99). There were no significant differences in occlusion level, age, ischemic change on 
initial imaging and degree of reperfusion between left- and right-sided strokes. Left-sided strokes had higher baseline 
NIHSS scores (p = 0.02) and lower admission SBP (p = 0.009). Independent predictors of outcome for left-sided strokes 
were NIHSS (p = 0.0002) and reperfusion (p = 0.006), and for right-sided strokes were age (p = 0.002) and reperfusion (p 
= 0.003). In univariate analysis, pre-treatment ischemic change on NCCT was associated with outcome only for left-
sided strokes (p = 0.05).
Conclusions: In anterior circulation proximal artery occlusions treated with IAT, hemispheric lateralization influences 
the clinical and imaging predictors of outcome. Most notably, NIHSS predicts outcome only for the left-sided strokes in 
this population. This finding has important implications for outcome prediction in the acute setting and indicates a 
need for stroke severity scales more sensitive to right hemispheric deficits.
Background
Numerous studies have explored the differences between
left- and right-hemispheric strokes, particularly with
regards to functional outcome [1-3], NIHSS score [4,5],
and imaging findings [4-6]. While certain findings are
widely accepted, such as weighting of the NIHSS toward
left-hemispheric function, conflicting data exists on the
impact of hemispheric lateralization on clinical out-
come[3]. Some variability may be related to differences in
study populations. In particular, many studies do not
adjust for the level of arterial occlusion, which is noted to
be a major determinant of outcome[7].
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Intracranial PAO represents a relatively homogeneous
p o p u l a t i o n  o f  A I S  t h a t  a c c o u n t s  f o r  t h e  m a j o r i t y  o f
stroke-related morbidity and mortality[8]. IAT is more
effective than intravenous thrombolysis for these proxi-
mal occlusions [9-11], and this recognition has led to a
dramatic growth in the utilization of endovascular thera-
pies[12]. Several studies, including one randomized, con-
trolled study, have explored the factors predictive of
outcome following IAT[9,11,13-20]. None have analyzed
these variables stratified by the side of involvement.
Baseline NIHSS score is widely recognized to be a
strong predictor of clinical outcome in acute ischemic
stroke[13,15,21,22]. Multiple studies comparing left- and
right-sided strokes have demonstrated that the NIHSS
underestimates stroke severity in right-sided strokes [4-
6], and this difference is most pronounced in large strokes
secondary to PAO[4]. Yet, no studies have explored
whether the prognostic ability of the NIHSS is influenced
by the side of stroke involvement in this population.
Our purpose was to characterize the effect of hemi-
spheric lateralization on functional outcome and the clin-
ical and imaging predictors of outcome in acute ischemic
stroke patients with PAO undergoing IAT.
Methods
Patient selection
This retrospective cohort study examined 35 consecutive
left-hemispheric and 35 consecutive right-hemispheric
stroke patients with anterior circulation PAO who under-
went IAT at Massachusetts General Hospital from June
2004 to August 2008. Inclusion criteria were: (1) acute
occlusion of the intracranial ICA and/or proximal MCA,
including stem (M1) and proximal branch lesions (M2),
on CTA; (2) treatment with IAT; and (3) available clinical
follow-up at three months. Medical records were
reviewed for clinical data. Our institutional review board
approved the study.
Imaging acquisition
All subjects underwent NCCT followed by CTA of the
head and neck performed on a 16- or 64-slice multi-
detector helical scanner (GE Medical Systems, Wauke-
sha, WI). NCCT was performed with 120-140kVp,
170mA, and 5-mm axial slice thickness. For CTA, non-
ionic low-osmolar iodinated contrast media (Isovue, 370
mg iodine/mL; Bracco Diagnostics, Princeton, NJ) was
injected via a peripheral intravenous catheter at 3.5 cc/s
for 100 cc, followed by 40 cc saline at 4.0 cc/s. Images
were acquired from the vertex to the aortic arch after an
8-10s delay, using 140 kVp, auto-mA (300-715 mA), 0.5s
rotation time, 1.25 mm helical thickness, 0.625 mm inter-
val, 0.938:1 pitch, 9.37 mm/rotation speed, 22 cm FOV.
CTA images were reconstructed in standard algorithm at
2.5 mm.
Treatment
Intra-arterial reperfusion therapy
Inclusion criteria are:(1) proximal artery occlusion (ICA,
MCA M1 or M2 branches) on CTA; (2) NCCT without
hemorrhage; (3) NCCT with hypodensity less than one-
third of the MCA territory, or a PWI-DWI mismatch
>20% with DWI abnormality <1/3rd of the MCA terri-
tory; and (4) ability to navigate a microcatheter to the
thrombus within eight hours from symptom onset.
Exclusion criteria are comparable to IV tPA criteria[23].
Mechanical/pharmacological treatments included the
MERCI Retriever (Concentric Medical Inc., Mountain
View, CA), microwire disruption, balloon angioplasty,
stent placement and IA urokinase infusion (5000U/cc,
maximum dose 750,000U). Some patients also received
IV tPA (bridging therapy): 0.9 mg/kg of IV tPA to a maxi-
mum of 90 mg[24].
Reperfusion was graded on post-treatment digital sub-
traction angiography with the Mori scale: grade 0--com-
plete occlusion; 1--distal movement of thrombus without
reperfusion; 2--reperfusion in <50% of the ischemic area;
3-->50% reperfusion; 4--complete recanalization/reper-
fusion[21]. We defined reperfusion as a Mori score ≥ 2.
Time from symptom onset to reperfusion was recorded.
Time to procedure termination was recorded for nonre-
canalizers (Mori 0-1).
Imaging analysis
The ASPECTS grading system was applied to the pre-
treatment NCCT and CTA-SI for each patient[25]. The
ten brain regions (caudate, lentiform nucleus, internal
capsule, insula, and six cortical regions) used to calculate
the ASPECTS score were inspected using the entire set of
images for each study. One point was deducted for each
affected region from a total possible score of ten. There-
fore, lower scores indicated more extensive ischemic
change. Readers were blinded to all clinical information
except for stroke side. Window width and level settings
were selected to optimize contrast between normal and
hypodense (ischemic) brain parenchyma. All imaging was
evaluated independently by three neuroradiologists (AY,
JR, PS), and differences were resolved by consensus.
Follow-up imaging from 12-72 hours after IAT was
reviewed to evaluate for hemorrhagic transformation
based on ECASS definitions: HI1 (small petechiae with-
out mass effect), HI2 (more confluent petechiae without
mass effect), PH1 (<30% of infarct with mild mass effect),
PH2 (>30% of infarct with significant mass effect)[26].Yoo et al. BMC Neurology 2010, 10:25
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Clinical scoring
The baseline NIHSS score was used to assess the neuro-
logic status of stroke patients in the emergency depart-
ment. Three-month mRS, the primary clinical endpoint,
was assessed by one of the stroke neurologists or neuro-
interventionalists, who were not blinded to clinical infor-
mation. An mRS ≤ 2 was considered a good outcome.
Statistical analysis
Univariate analysis of clinical, imaging and outcome data
was performed comparing left- and right-hemispheric
stroke patients. Subsequently, univariate analysis com-
paring good and poor outcome was performed for each
hemisphere. The Fisher's exact test was used for categori-
cal variables. The Student's t test was used for normally-
distributed continuous variables. The Mann-Whitney U
test was used for ordinal data. A stepwise multiple logis-
tic regression was performed to identify independent
predictors of outcome. Normality was tested with the
Kolmogorov-Smirnov test. Statistical analysis was per-
formed utilizing the SAS 9.1 software package (SAS Insti-
tute Inc., Cary, NC) and MedCalc® 10.0 Software.
Results
Baseline characteristics and clinical outcome: entire cohort
Table 1 lists the baseline and post-treatment characteris-
tics of the entire study population. Thirty-eight of the 70
patients were females (54.3%); mean age was 67.1 ± 18.4
years; median NIHSS score was 18 (interquartile range
IQR, 14-21). There were 21 terminal ICA occlusions, all
extending into the proximal MCA. There were 49 MCA
occlusions: 40 involved the M1 segment and 9 involved
a n  M 2  s e g m e n t .  T h e  m e d i a n  N C C T  A S P E C T S  w a s  8
(IQR, 6-9). The median CTA-SI ASPECTS was 5 (IQR, 3-
7).
The median Mori reperfusion score was 2 (IQR, 1-3).
The mean time to reperfusion or procedure termination
was 411.2 ± 153.2 minutes. Nineteen patients (27.1%) had
a good outcome (mRS ≤ 2) at three months. Twenty-five
patients (35.7%) died. The median mRS was 4 (IQR, 2-6).
Independent predictors of good three-month outcome
for the entire cohort were Mori reperfusion score (O.R.
11.4, 95% C.I. 2.84-45.5, p < 0.0001), age (O.R. 0.93, 95%
C.I. 0.88-0.98, P = 0.0004), and NIHSS score (O.R. 0.79,
95% C.I. 0.64-0.98, p = 0.02). NCCT ASPECTS and CTA-
SI ASPECTS were not statistically different between
patients with good and poor outcome.
Of sixty-seven patients with post-treatment imaging,
hemorrhagic transformation was detected in 39 patients
(58.2%): 27 HI1, 8 HI2, 1 PH1 and 3 PH2. There was a
4.5% rate of significant hemorrhagic transformation
(PH2), which is within reported rates for IAT[9,11,20]. Of
three patients with PH2, one had a left M1 occlusion with
mRS of 5, one had a right M1 occlusion with mRS of 3,
and one had a right M1 occlusion and died.
Baseline characteristics and clinical outcome: left- versus 
right-hemispheric strokes
Table 2 compares left- and right-hemispheric strokes for
baseline variables, reperfusion and clinical outcome. Left-
sided strokes had higher NIHSS scores (p = 0.02) and
lower admission SBP (p = 0.009). The remaining baseline
variables were not statistically different, including age,
occlusion level, and ASPECTS.
There were no significant differences in the degree of
reperfusion, clinical outcome and hemorrhage rate
between the two hemispheres. The median Mori score
Table 1: Baseline and Post-Treatment Clinical and Imaging 
Characteristics, Entire Cohort (n = 70 patients)
Age, y, mean ± SD (range) 67.1 ± 18.4 (18-93)
Female, no. (%) 38 (54.3)
Baseline NIHSS score, median 
(IQR), range
18 (14-21), 4-30
Admission Glucose level, 
mean ± SD
142.5 ± 44.0
Admission SBP, mean ± SD 158.4 ± 32.2
Atrial fibrillation, no. (%) 32 (45.7)
Diabetes, no. (%) 18 (25.7)
IV tPA treatment, no. (%) 29 (41.4)
Time to imaginga, minutes, 
mean ± SD
195.6 ± 137.6
Baseline NCCT ASPECTS, 
median (IQR), range
8 (6-9), 2-10
Baseline CTA-SI ASPECTS, 
median (IQR), range
5 (3-7), 0-10
ICA:M1:M2, no. 21:40:9
Time to vessel openinga, 
minutes, mean ± SD
411.2 ± 153.2
Mori reperfusion score, 
median (IQR), range
2 (1-3)
Post-treatment hemorrhage, 
no. (%)
39 (58.2)b
Good 3-month outcome 
(mRS ≤ 2), no. (%)
19 (27.1)
Abbreviations: NIHSS, National Institutes of Health Stroke Scale; 
SBP, systolic blood pressure; IV tPA, intravenous tissue 
plasminogen activator; NCCT, noncontrast head CT; CTA-SI, CT 
angiographic source images; ASPECTS, Alberta Stroke Program 
Early CT Score; ICA, internal carotid artery; M1, middle cerebral 
artery stem (M1 segment); M2, middle cerebral artery post-
bifurcation segment (M2 segment); mRS, modified Rankin Scale 
score.
a Defined as time from stroke onset.
b Denominator is 67 patients who had available follow-up 
imaging.Yoo et al. BMC Neurology 2010, 10:25
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for both sides was 2 (IQR, 1-3; P = 0.44). Nine of 35
patients (25.7%) with left-sided strokes versus 10 of 35
patients (28.6%) with right-sided strokes had a good out-
come (p = 0.99). Hemorrhage occurred in 17/33 (51.5%)
left-sided strokes and 22/35 (62.9%) right-sided strokes (p
= 0.46).
Predictors of outcome: left-versus right-hemispheric 
strokes
For left-sided strokes, univariate predictors of outcome
were lower NIHSS score (p = 0.0008) and greater reperfu-
sion (p = 0.003, Table 3). There was a strong statistical
trend for higher NCCT ASPECTS (p = 0.05) and CTA-SI
ASPECTS (p = 0.06) in patients with good outcomes (Fig-
ure 1). Independent predictors of good outcome were
NIHSS score (O.R. 0.51, 95% C.I. 0.28-0.92, p = 0.0002)
and Mori reperfusion score (O.R. 21.3, 95% C.I. 1.13-500,
p = 0.006).
For right-sided strokes, univariate predictors of out-
come were younger age (p = 0.009) and greater reperfu-
sion (p = 0.006, Table 4). There was no association of pre-
treatment ASPECTS with outcome (Figure 2). Indepen-
dent predictors of good outcome were age (O.R. 0.89, 95%
C.I. 0.80-0.98, p = 0.002) and Mori score (O.R. 12.0, 95%
C.I. 1.40-100, p = 0.003).
Discussion
In this study of acute ischemic stroke patients with ante-
rior circulation PAO who underwent IAT, the predictors
of three-month functional outcome differed by the side of
stroke involvement. Namely, for left-sided strokes, base-
line NIHSS score, degree of reperfusion, and potentially
pre-treatment NCCT ASPECTS predicted outcome,
while for right-sided strokes, degree of reperfusion and
age were predictors. Despite this finding, there was no
significant difference in the rates of good outcome
between left- and right-hemispheric strokes.
Importantly, the left- and right-sided stroke cohorts
were well matched for major variables previously associ-
ated with clinical outcome after IAT, including
age[15,17,19], occlusion level[14,27], and recanaliza-
tion[11,13,14,16,17,19]. Although there was a significant
difference in median NIHSS score (another important
variable[13,15,19]) of 4 points, this mismatch more likely
reflected the inherent bias of the NIHSS for left-hemi-
spheric function rather than a true difference in stroke
severity, as the levels of occlusion were nearly identical (p
= 0.92), and there were no significant differences in pre-
treatment ASPECTS (p = 0.22). Supporting this view is a
study which demonstrated that left-sided stroke patients
with total anterior circulation syndromes scored 4 points
Table 2: Left- vs Right-Hemispheric Strokes, Baseline and Post-Treatment Characteristics and Outcome
Left hemisphere (n = 35) Right hemisphere
(n = 35)
P value Test
Age, y, mean ± SD 68.9 ± 18.0 65.3 ± 18.9 0.41 Student's T
Female, no. (%) 22 (62.9) 16 (45.7) 0.23 Fisher's exact
Baseline NIHSS score, median (IQR) 20 (17-22) 16 (14-19) 0.02 Mann-Whitney
Admission Glucose, mean ± SD 133.8 ± 35.9 151.1 ± 49.8 0.10 Student's T
Admission SBP, mean ± SD 148.6 ± 30.4 168.4 ± 31.3 0.009 Student's T
Atrial fibrillation, no. (%) 18 (51.4) 14 (40) 0.47 Fisher's exact
Diabetes, no. (%) 8 (22.9) 10 (28.6) 0.79 Fisher's exact
IV tPA treatment, no. (%) 12 (34.3) 17 (48.6) 0.33 Fisher's exact
Time to imaginga, minutes, mean ± SD 215.1 ± 142.8 176.2 ± 131.4 0.24 Student's T
Baseline NCCT ASPECTS, median (IQR) 8 (6-8.75) 8 (6-9.75) 0.22 Mann-Whitney
Baseline CTA-SI ASPECTS, median (IQR) 5 (2-7) 5 (3-7) 0.59 Mann-Whitney
ICA:M1:M2, no. 10:20:05 11:20:04 0.92 Chi-square
Time to vessel openinga, minutes, mean ± SD 420.0 ± 159.8 402.5 ± 148.1 0.63 Student's T
Mori reperfusion score, median (IQR) 2 (1-3) 2 (1-3) 0.44 Mann-Whitney
Post-treatment hemorrhage, no. (%) 17 (51.5)b 22 (62.9) 0.34 Fisher's exact
Good 3-month outcome (mRS ≤ 2), no. (%) 9 (25.7) 10 (28.6) 0.99 Fisher's exact
Abbreviations: NIHSS, National Institutes of Health Stroke Scale; SBP, systolic blood pressure; IV tPA, intravenous tissue plasminogen activator; 
NCCT, noncontrast head CT; CTA-SI, CT angiographic source images; ASPECTS, Alberta Stroke Program Early CT Score; ICA, internal carotid artery; 
M1, middle cerebral artery stem (M1 segment); M2, middle cerebral artery post-bifurcation segment (M2 segment); mRS, modified Rankin Scale 
score.
a Defined as time from stroke onset; b Denominator is 33 patients who had available follow-up imaging.Yoo et al. BMC Neurology 2010, 10:25
http://www.biomedcentral.com/1471-2377/10/25
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Figure 1 Left-sided strokes, Box-and-whisker plots. A. Median NCCT ASPECTS for good vs. poor outcome is 8 vs. 7 (P = 0.05). B. Median CTA-SI 
ASPECTS for good vs. poor outcome is 7 vs. 4.5 (P = 0.06). Good outcome is defined as modified Rankin Scale score ≤ 2 at 3 months. Abbreviations: 
NCCT, noncontrast head CT; CTA-SI, CT angiographic source images; ASPECTS, Alberta Stroke Program Early CT Score.Yoo et al. BMC Neurology 2010, 10:25
http://www.biomedcentral.com/1471-2377/10/25
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higher on the NIHSS than right-sided stroke patients
with larger stroke volumes[4].
Evidence from studies assessing stroke outcome by side
of involvement is inconclusive, with some studies demon-
strating more favorable outcomes for left-hemispheric
strokes and others demonstrating the converse[1,3]. The
largest study is the recent retrospective analysis of the
VISTA database, which pooled data from stroke trials
reporting lateralization[3]. Assessing 1644 placebo-
treated patients, the authors found no difference in func-
tional outcome between the two hemispheres, which is in
agreement with our findings. The conflicting data may be
related to differences in study populations. The previous
studies examined patient cohorts encompassing a broad
range of stroke severity, including lacunar and total ante-
rior circulation syndromes[1,3]. In comparing left-versus
right-hemispheric strokes, most studies did not adjust for
occlusion level, which could potentially influence results.
Furthermore, the VISTA analysis included posterior cir-
culation strokes as well as 163 intracerebral hemorrhages.
Clinical Predictors of Outcome
Numerous studies have shown that baseline NIHSS score
predicts outcome in stroke patients who receive IV and/
or IA therapies[13,15,19,22]. In our study, it was an inde-
pendent predictor of outcome for the entire cohort. How-
ever, when analyzing outcome by side, NIHSS score was
an independent predictor of outcome only for left-sided
strokes. By contrast, the VISTA analysis demonstrated a
significant correlation between NIHSS and outcome for
both hemispheres[3]. The likely explanation is that over a
broad range of stroke severity (as seen in the VISTA data-
base) NIHSS score is a reasonable surrogate for occlusion
level, even for right-sided strokes. For a homogeneous
population of large vessel occlusions (as in our study),
NIHSS score may not adequately discriminate the
amount of territory at risk in the right hemisphere. This
last point is supported by numerous imaging studies that
have demonstrated that patients with right-sided strokes
may have low NIHSS scores despite substantial infarct
volumes [4-6].
Similarly, age was an independent predictor of outcome
for right-sided but not for left-sided strokes. Age likely
emerged as a predictor for the right hemisphere due to
the absence of an NIHSS effect. As expected, reperfusion
was an independent predictor of outcome for both hemi-
spheres.
If verified in future studies, these findings have signifi-
cant implications for treatment selection, acute prognos-
tication, and clinical investigation of anterior circulation
stroke patients undergoing IAT. Based on our results,
using the NIHSS to stratify PAO patients by stroke sever-
Table 3: Univariate Predictors of Outcome, Left-Hemispheric Strokes
Poor, left (n = 26) Good, left (n = 9) P value Test
Age, y, mean ± SD 70.6 ± 17.8 64.1 ± 19.1 0.36 Student's T
Female, no. (%) 14 (53.8) 8 (88.9) 0.11 Fisher's exact
Baseline NIHSS score, median (IQR) 21 (18-22) 14 (9-17) <0.001 Mann-Whitney
Admission Glucose, mean ± SD 133.8 ± 35.1 133.9 ± 40.3 0.99 Student's T
Admission SBP, mean ± SD 151.7 ± 31.3 139.8 ± 27.3 0.32 Student's T
Atrial fibrillation, no. (%) 13 (50) 5 (55.6) 0.99 Fisher's exact
Diabetes, no. (%) 5 (19.2) 3 (33.3) 0.40 Fisher's exact
IV tPA treatment, no. (%) 8 (30.8) 4 (44.4) 0.69 Fisher's exact
Time to imaginga, minutes, mean ± SD 227.2 ± 153.5 180.1 ± 105.4 0.40 Student's T
Baseline NCCT ASPECTS, median (IQR) 7 (5-8) 8 (8-9) 0.05 Mann-Whitney
Baseline CTA-SI ASPECTS, median (IQR) 4.5 (2-6) 7 (5.25-8) 0.06 Mann-Whitney
ICA:M1:M2, no. 8:15:3 2:5:2 0.70 Chi-square
Time to vessel openinga, minutes, mean 
± SD
435.1 ± 173.8 376.4 ± 105.6 0.35 Student's T
Mori reperfusion score, median (IQR) 2 (0-2) 3 (2-3.25) 0.003 Mann-Whitney
Post-treatment hemorrhage, no. (%) 14 (56)b 3 (37.5)c 0.44 Fisher's exact
Abbreviations: NIHSS, National Institutes of Health Stroke Scale; SBP, systolic blood pressure; IV tPA, intravenous tissue plasminogen activator; 
NCCT, noncontrast head CT; CTA-SI, CT angiographic source images; ASPECTS, Alberta Stroke Program Early CT Score; mRS, modified Rankin Scale 
score.
a Defined as time from stroke onset; b Denominator is 25 patients who had available follow-up imaging; c Denominator is 8 patients who had 
available follow-up imaging.Yoo et al. BMC Neurology 2010, 10:25
http://www.biomedcentral.com/1471-2377/10/25
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Figure 2 Right-sided strokes, Box-and-whisker plots. A. Median NCCT ASPECTS for good vs. poor outcome is 8 vs. 8 (P = 0.83). B. Median CTA-SI 
ASPECTS for good vs. poor outcome is 5 vs. 5 (P = 0.66). Good outcome is defined as modified Rankin Scale score ≤ 2 at 3 months. Abbreviations: NCCT, 
noncontrast head CT; CTA-SI, CT angiographic source images; ASPECTS, Alberta Stroke Program Early CT Score.Yoo et al. BMC Neurology 2010, 10:25
http://www.biomedcentral.com/1471-2377/10/25
Page 8 of 11
ity should be done only for left-hemispheric strokes.
Right-hemispheric strokes secondary to PAO should be
stratified using a clinical scale tailored to the right hemi-
sphere[4].
Imaging Predictors of Outcome
Neither NCCT nor CTA-SI ASPECTS predicted clinical
outcome in the entire patient cohort. However, both
ASPECTS scores appeared to predict outcome for left-
sided strokes. Patients with left-sided strokes and good
outcome had higher NCCT ASPECTS (8 vs. 7, p = 0.05)
and CTA-SI ASPECTS (7 vs. 4.5, p = 0.06) scores on pre-
treatment imaging than those with poor outcome (Figure
1). No such association between ASPECTS and outcome
was seen in right-hemispheric strokes (Figure 2). The lack
of a relationship between ischemic burden and outcome
in the right hemisphere confirms the findings of a previ-
ous study which identified a subset of right-sided stroke
patients who had good outcomes despite substantial
lesion volumes[6]. No such group was found among the
left-sided stroke patients in that study.
Published studies of IAT that have assessed predictors
of outcome either have not mentioned the side of involve-
ment[11,14,17-19,28], or have not analyzed left- and
right-sided strokes separately [15,16]. Only two studies
present their outcomes by the involved hemisphere,
although no analysis is performed comparing the two
groups[2,16]. This may explain why some studies that
have assessed both pre-treatment imaging and outcome
have found an association[15,28] and some have
not[2,14,16-19]. The difference may depend on the pro-
portion of left-versus right-sided strokes in a particular
study.
One plausible explanation for the imaging findings is
that language localizes to the left hemisphere in 88-96%
of right-handed and 73-4% of left-handed people [29,30].
Furthermore, many anatomic structures responsible for
speech are localized to the peri-insular region, including
Broca's area[31]. Because of the nature of the pial collat-
eral circulation, the peri-insular region has the most
severe reduction in blood flow and progresses to infarc-
Table 4: Univariate Predictors of Outcome, Right-Hemispheric Strokes
Poor, right (n = 25) Good, right (n = 10) P value Test
Age, y, mean ± SD 70.4 ± 17.8 52.4 ± 15.6 0.009 Student's T
Female, no. (%) 12 (48) 4 (40) 0.72 Fisher's exact
Baseline NIHSS score, 
median (IQR)
16 (14-20) 15.5 (14-18) 0.73 Mann-Whitney
Admission Glucose, mean ± SD 149.0 ± 54.8 156.3 ± 36.4 0.70 Student's T
Admission SBP, mean ± SD 171.1 ± 33.9 162.1 ± 24.1 0.45 Student's T
Atrial fibrillation, no. (%) 11 (44) 3 (30) 0.70 Fisher's exact
Diabetes, no. (%) 6 (24) 4 (40) 0.42 Fisher's exact
IV tPA treatment, no. (%) 14 (56) 3 (30) 0.26 Fisher's exact
Time to imaginga, minutes, 
mean ± SD
177.8 ± 147.7 172.1 ± 83.6 0.91 Student's T
Baseline NCCT ASPECTS, 
median (IQR)
8 (6-10) 8 (6-9) 0.83 Mann-Whitney
Baseline CTA-SI ASPECTS, 
median (IQR)
5 (3-7) 5 (4-8) 0.66 Mann-Whitney
ICA:M1:M2, no. 9:12:4 2:8:0 0.18 Chi-square
Time to vessel openinga, 
minutes, mean ± SD
418.1 ± 158.7 363.4 ± 115.3 0.33 Student's T
Mori reperfusion score, 
median (IQR)
2 (1-2.25) 3 (3-3) 0.006 Mann-Whitney
Post-treatment hemorrhage, 
no. (%)
18 (72) 4 (40) 0.12 Fisher's exact
Abbreviations: NIHSS, National Institutes of Health Stroke Scale; SBP, systolic blood pressure; IV tPA, intravenous tissue plasminogen activator; 
NCCT, noncontrast head CT; CTA-SI, CT angiographic source images; ASPECTS, Alberta Stroke Program Early CT Score; mRS, modified Rankin 
Scale score.
a Defined as time from stroke onsetYoo et al. BMC Neurology 2010, 10:25
http://www.biomedcentral.com/1471-2377/10/25
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tion most rapidly with ICA and proximal MCA occlu-
sions. Therefore, in the usually dominant left hemisphere,
even modest infarcts will likely have a negative impact on
language and clinical outcome, which may explain why
smaller infarct burden is associated with better outcome
on the left.
While incompletely understood, poor outcomes in
right-hemispheric strokes are thought to be related to
cognitive deficits, most notably neglect[2,32]. Previous
studies of neglect have implicated the right superior tem-
poral gyrus and inferior parietal lobule[33]. Because they
lie distally in the MCA territory, an infarct has to be rela-
tively large to involve these regions, and therefore, more
infarct burden can be sustained before having a negative
clinical effect.
These findings could have significant implications for
imaging selection in acute stroke therapy. They highlight
the weakness of volumetric-based analysis that does not
account for eloquence[34].
Admission SBP and Hemispheric Lateralization
Our patients with right-hemispheric stroke demonstrated
significantly higher mean admission SBP than those with
left-hemispheric stroke (168.4 mmHg vs 148.6 mmHg, p
= 0.009). This finding was also demonstrated by Meyer et
al, who showed that the increase in blood pressure for
right-sided strokes was accompanied by significantly
increased plasma catecholamine levels[35] and that these
changes were mediated by infarction of the insular cor-
tex, the area most at risk in our patients. The autonomic
role of the right insular cortex is also supported by a study
demonstrating that right insular infarction is associated
with elevated serum cardiac troponin T levels[36], medi-
ated by excessive sympathetic activation. It is important
to note that there was no significant difference in the
admission SBP between our patients with good versus
poor outcome.
Limitations
One limitation of this study is the small number of sub-
jects, particularly those with good outcome. This reflects
the highly selected nature of our study population, as well
as the generally poor natural history of patients with
proximal intracranial artery occlusion. This aspect of the
study may have limited our ability to distinguish differ-
ences in the rates of good outcome between the two
hemispheres. However, despite the small study popula-
tion, we were able to demonstrate significant differences
in predictors of outcome, particularly with respect to the
NIHSS. Clearly, our findings need to be verified in larger
studies. Additionally, the retrospective nature of this
analysis introduces potential biases that should be
addressed in prospective studies. While the left- and
right-sided strokes in this study had similar stroke severi-
ties as reflected by the level of arterial occlusion and the
extent of pre-treatment ischemic change on imaging,
future studies should incorporate quantitative or semi-
quantitative assessments of the pial collateral circulation
in their analyses.
Conclusions
In anterior circulation proximal artery strokes treated
with IAT, NIHSS predicts outcome only for left-sided
strokes, highlighting the need for clinical scales that are
more sensitive to right hemispheric function. Addition-
ally, pre-treatment ischemic change on NCCT and CTA
source images may be associated with outcome only for
the left hemisphere, which has important consequences
for using imaging selection to guide therapy. These pre-
liminary findings need to be verified in larger, prospective
studies, and may have significant implications for both
clinical management and research methodology.
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